While one study reported complete CD31 negativity in both medullary MM and MM-EMD [11], another study described 93% of PC myeloma and 80% of plasmablastic variants of myelomas to be CD31 positive [12]. This evidence concerns the gene PECAM1 and plasma cell myeloma.